AGLARIS LIMITED

Company number 09111674 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£6,985,530

Balance sheet as at 2025-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2014-07-02
Employees
1 (2025 accounts · was 2 in 2024)
Registered office
167-169 Great Portland Street Great Portland Street, 5th Floor, London, England, W1W 5PF
Postcode
W1W 5PF
Capital
50 GBP
Accounts category
Total Exemption Full
Charges
0 outstanding

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-10-16
Next due by
2026-10-30
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 8 current · 5 resigned

S.L. 3-GUTINVER Corporate Director
Appointed 2024-03-22
Appointed 2020-05-19
BIO CELL GLOBAL INVESTMENTS S.L Corporate Director · corporate
Appointed 2016-04-25
Appointed 2016-04-25
Appointed 2015-12-18

View all officers and resignations →

Group structure

Controlled by Crb Bio Ii, Fcr (V86505468) — since 2019-02-28

From persons-with-significant-control filings on the public register.

Previous registered addresses 1

AddressChanged on
LONDON BIOSCIENCE INNOVATION CENTRE 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH2016-10-06

Among its peers

Top 10%

by shareholders' funds, of 141 similar companies in W

Among the oldest 25% of its local peers, trading since 2014.

No.10 of the largest research and experimental development on biotechnology companies in London →

32,446 companies are registered at this postcode →

Competitors London

This company ranks 10 among research and experimental development on biotechnology in London.

Full league table →

The class of 2014

38%

of the 357 companies in this sector incorporated in 2014 are still active today; 59% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →